Table 4.
Cox regression analyses on liver-related survival. Uni- and multivariate cox regression analysis on liver-related survival in non-ACLD and ACLD patients.
Patient characteristics | Univariate Analysis | Multivariate Analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | p value | HR | 95%CI | p value | |
non-ACLD (738 patients, 7 liver-related deaths (0.95%)) | ||||||
age [per year] | 1.161 | 1.074–1.254 | <0.001 | 1.174 | 1.075–1.283 | <0.001 |
sex [female vs. male] | 0.473 | 0.092–2.437 | 0.371 | 0.453 | 0.081–2.519 | 0.365 |
arterial hypertension | 1.800 | 0.403–8.051 | 0.442 | 0.858 | 0.146–5.051 | 0.865 |
statin indication | ||||||
- indication but no statin vs. no indication | 5.568 | 1.019–30.420 | 0.047 | 4.094 | 0.629–26.658 | 0.140 |
- on statin vs. indication but no statin | 0.247 | 0.022–2.724 | 0.253 | 0.088 | 0.006–1.200 | 0.068 |
BMI [per kg/m2] | 0.923 | 0.785–1.089 | 0.335 | 0.943 | 0.751–1.185 | 0.615 |
ACLD (527 patients, 30 liver-related deaths deaths (5.69%)) | ||||||
age [per year] | 1.032 | 0.997–1.067 | 0.071 | 1.026 | 0.991–1.062 | 0.145 |
sex [female vs. male] | 1.239 | 0.597–2.572 | 0.566 | 1.203 | 0.571–2.537 | 0.627 |
arterial hypertension | 1.613 | 0.787–3.304 | 0.192 | 1.780 | 0.808–3.921 | 0.152 |
diabetes mellitus | 0.933 | 0.416–2.097 | 0.868 | 1.012 | 0.404–2.538 | 0.979 |
statin indication | ||||||
- indication but no statin vs. no indication | 1.073 | 0.371–3.104 | 0.897 | 1.020 | 0.312–3.335 | 0.975 |
- on statin vs indication but no statin | 0.699 | 0.156–3.123 | 0.639 | 0.605 | 0.133–2.761 | 0.517 |
BMI [per kg/m2] | 0.922 | 0.857–0.991 | 0.028 | 0.912 | 0.841–0.989 | 0.025 |